Cargando…
_version_ 1783570999105552384
author Noë, Michaël
Niknafs, Noushin
Fischer, Catherine G.
Hackeng, Wenzel M.
Beleva Guthrie, Violeta
Hosoda, Waki
Debeljak, Marija
Papp, Eniko
Adleff, Vilmos
White, James R.
Luchini, Claudio
Pea, Antonio
Scarpa, Aldo
Butturini, Giovanni
Zamboni, Giuseppe
Castelli, Paola
Hong, Seung-Mo
Yachida, Shinichi
Hiraoka, Nobuyoshi
Gill, Anthony J.
Samra, Jaswinder S.
Offerhaus, G. Johan A.
Hoorens, Anne
Verheij, Joanne
Jansen, Casper
Adsay, N. Volkan
Jiang, Wei
Winter, Jordan
Albores-Saavedra, Jorge
Terris, Benoit
Thompson, Elizabeth D.
Roberts, Nicholas J.
Hruban, Ralph H.
Karchin, Rachel
Scharpf, Robert B.
Brosens, Lodewijk A. A.
Velculescu, Victor E.
Wood, Laura D.
author_facet Noë, Michaël
Niknafs, Noushin
Fischer, Catherine G.
Hackeng, Wenzel M.
Beleva Guthrie, Violeta
Hosoda, Waki
Debeljak, Marija
Papp, Eniko
Adleff, Vilmos
White, James R.
Luchini, Claudio
Pea, Antonio
Scarpa, Aldo
Butturini, Giovanni
Zamboni, Giuseppe
Castelli, Paola
Hong, Seung-Mo
Yachida, Shinichi
Hiraoka, Nobuyoshi
Gill, Anthony J.
Samra, Jaswinder S.
Offerhaus, G. Johan A.
Hoorens, Anne
Verheij, Joanne
Jansen, Casper
Adsay, N. Volkan
Jiang, Wei
Winter, Jordan
Albores-Saavedra, Jorge
Terris, Benoit
Thompson, Elizabeth D.
Roberts, Nicholas J.
Hruban, Ralph H.
Karchin, Rachel
Scharpf, Robert B.
Brosens, Lodewijk A. A.
Velculescu, Victor E.
Wood, Laura D.
author_sort Noë, Michaël
collection PubMed
description Intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms (MCNs) are non-invasive neoplasms that are often observed in association with invasive pancreatic cancers, but their origins and evolutionary relationships are poorly understood. In this study, we analyze 148 samples from IPMNs, MCNs, and small associated invasive carcinomas from 18 patients using whole exome or targeted sequencing. Using evolutionary analyses, we establish that both IPMNs and MCNs are direct precursors to pancreatic cancer. Mutations in SMAD4 and TGFBR2 are frequently restricted to invasive carcinoma, while RNF43 alterations are largely in non-invasive lesions. Genomic analyses suggest an average window of over three years between the development of high-grade dysplasia and pancreatic cancer. Taken together, these data establish non-invasive IPMNs and MCNs as origins of invasive pancreatic cancer, identifying potential drivers of invasion, highlighting the complex clonal dynamics prior to malignant transformation, and providing opportunities for early detection and intervention.
format Online
Article
Text
id pubmed-7428044
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-74280442020-08-28 Genomic characterization of malignant progression in neoplastic pancreatic cysts Noë, Michaël Niknafs, Noushin Fischer, Catherine G. Hackeng, Wenzel M. Beleva Guthrie, Violeta Hosoda, Waki Debeljak, Marija Papp, Eniko Adleff, Vilmos White, James R. Luchini, Claudio Pea, Antonio Scarpa, Aldo Butturini, Giovanni Zamboni, Giuseppe Castelli, Paola Hong, Seung-Mo Yachida, Shinichi Hiraoka, Nobuyoshi Gill, Anthony J. Samra, Jaswinder S. Offerhaus, G. Johan A. Hoorens, Anne Verheij, Joanne Jansen, Casper Adsay, N. Volkan Jiang, Wei Winter, Jordan Albores-Saavedra, Jorge Terris, Benoit Thompson, Elizabeth D. Roberts, Nicholas J. Hruban, Ralph H. Karchin, Rachel Scharpf, Robert B. Brosens, Lodewijk A. A. Velculescu, Victor E. Wood, Laura D. Nat Commun Article Intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms (MCNs) are non-invasive neoplasms that are often observed in association with invasive pancreatic cancers, but their origins and evolutionary relationships are poorly understood. In this study, we analyze 148 samples from IPMNs, MCNs, and small associated invasive carcinomas from 18 patients using whole exome or targeted sequencing. Using evolutionary analyses, we establish that both IPMNs and MCNs are direct precursors to pancreatic cancer. Mutations in SMAD4 and TGFBR2 are frequently restricted to invasive carcinoma, while RNF43 alterations are largely in non-invasive lesions. Genomic analyses suggest an average window of over three years between the development of high-grade dysplasia and pancreatic cancer. Taken together, these data establish non-invasive IPMNs and MCNs as origins of invasive pancreatic cancer, identifying potential drivers of invasion, highlighting the complex clonal dynamics prior to malignant transformation, and providing opportunities for early detection and intervention. Nature Publishing Group UK 2020-08-14 /pmc/articles/PMC7428044/ /pubmed/32796935 http://dx.doi.org/10.1038/s41467-020-17917-8 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Noë, Michaël
Niknafs, Noushin
Fischer, Catherine G.
Hackeng, Wenzel M.
Beleva Guthrie, Violeta
Hosoda, Waki
Debeljak, Marija
Papp, Eniko
Adleff, Vilmos
White, James R.
Luchini, Claudio
Pea, Antonio
Scarpa, Aldo
Butturini, Giovanni
Zamboni, Giuseppe
Castelli, Paola
Hong, Seung-Mo
Yachida, Shinichi
Hiraoka, Nobuyoshi
Gill, Anthony J.
Samra, Jaswinder S.
Offerhaus, G. Johan A.
Hoorens, Anne
Verheij, Joanne
Jansen, Casper
Adsay, N. Volkan
Jiang, Wei
Winter, Jordan
Albores-Saavedra, Jorge
Terris, Benoit
Thompson, Elizabeth D.
Roberts, Nicholas J.
Hruban, Ralph H.
Karchin, Rachel
Scharpf, Robert B.
Brosens, Lodewijk A. A.
Velculescu, Victor E.
Wood, Laura D.
Genomic characterization of malignant progression in neoplastic pancreatic cysts
title Genomic characterization of malignant progression in neoplastic pancreatic cysts
title_full Genomic characterization of malignant progression in neoplastic pancreatic cysts
title_fullStr Genomic characterization of malignant progression in neoplastic pancreatic cysts
title_full_unstemmed Genomic characterization of malignant progression in neoplastic pancreatic cysts
title_short Genomic characterization of malignant progression in neoplastic pancreatic cysts
title_sort genomic characterization of malignant progression in neoplastic pancreatic cysts
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428044/
https://www.ncbi.nlm.nih.gov/pubmed/32796935
http://dx.doi.org/10.1038/s41467-020-17917-8
work_keys_str_mv AT noemichael genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT niknafsnoushin genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT fischercatherineg genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT hackengwenzelm genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT belevaguthrievioleta genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT hosodawaki genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT debeljakmarija genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT pappeniko genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT adleffvilmos genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT whitejamesr genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT luchiniclaudio genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT peaantonio genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT scarpaaldo genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT butturinigiovanni genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT zambonigiuseppe genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT castellipaola genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT hongseungmo genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT yachidashinichi genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT hiraokanobuyoshi genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT gillanthonyj genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT samrajaswinders genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT offerhausgjohana genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT hoorensanne genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT verheijjoanne genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT jansencasper genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT adsaynvolkan genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT jiangwei genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT winterjordan genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT alboressaavedrajorge genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT terrisbenoit genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT thompsonelizabethd genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT robertsnicholasj genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT hrubanralphh genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT karchinrachel genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT scharpfrobertb genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT brosenslodewijkaa genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT velculescuvictore genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts
AT woodlaurad genomiccharacterizationofmalignantprogressioninneoplasticpancreaticcysts